m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT05642
|
[1] | |||
m6A modification
Circ_RERE
Circ_RERE
YTHDF2
: m6A sites
Direct
Inhibition
Non-coding RNA
CircRERE
miR-195-5p
lncRNA miRNA circRNA
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | |||
| m6A Target | Circ_RERE | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Non-coding RNA (ncRNA) | ||||
| Epigenetic Regulator | Circ_RERE | circRNA | View Details | ||
| Regulated Target | hsa-miR-195-5p | View Details | |||
| Crosstalk Relationship | m6A → ncRNA | Inhibition | |||
| Crosstalk Mechanism | m6A regulators directly modulate the functionality of ncRNAs through specific targeting ncRNA | ||||
| Crosstalk Summary | Circ_RERE expression is downregulated in human osteoarthritis (OA) cartilage and chondrocytes, and circRERE downregulation is likely attributed to its increased m6A modification prone to endoribonucleolytic cleavage by YTHDF2-HRSP12-RNase P/MRP. Mechanistically, circRERE downregulation leads to aberrant beta-catenin ubiquitin and degradation by targeting hsa-miR-195-5p/IRF2BPL during OA pathogenesis. | ||||
| Responsed Disease | Osteoarthritis | ICD-11: FA05 | |||
| Responsed Drug | ICG-001 | ||||
| Cell Process | Cell apoptosis | ||||
: m6A sites